Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,422 | 183 | 97.5% |
| Education | $88.82 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $975.68 | 45 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $354.60 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $325.63 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $315.37 | 17 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $118.99 | 1 | $0 (2017) |
| PFIZER INC. | $105.28 | 6 | $0 (2023) |
| EVOKE PHARMA, INC. | $89.63 | 5 | $0 (2024) |
| UCB, Inc. | $81.86 | 5 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $79.11 | 5 | $0 (2024) |
| Celgene Corporation | $68.15 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,134 | 54 | ABBVIE INC. ($365.78) |
| 2023 | $873.83 | 44 | AbbVie Inc. ($324.55) |
| 2022 | $281.40 | 17 | ABBVIE INC. ($46.81) |
| 2021 | $275.63 | 12 | Janssen Biotech, Inc. ($95.18) |
| 2020 | $62.06 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($32.72) |
| 2019 | $251.23 | 16 | UCB, Inc. ($50.65) |
| 2018 | $190.51 | 13 | AbbVie, Inc. ($46.84) |
| 2017 | $441.73 | 25 | Janssen Scientific Affairs, LLC ($118.99) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/10/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $98.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $89.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/17/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GI COLON PREP | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Immunology | ||||||
| 08/27/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Gastroenterology | ||||||
| 08/22/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Immunology | ||||||
| 07/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 751 | 883 | $171,569 | $71,090 |
| 2022 | 14 | 706 | 862 | $161,118 | $70,487 |
| 2021 | 15 | 692 | 861 | $153,192 | $67,083 |
| 2020 | 15 | 614 | 773 | $133,543 | $58,708 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 91 | 91 | $42,770 | $17,826 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 113 | $17,628 | $8,549 | 48.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 79 | 80 | $20,800 | $7,351 | 35.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 42 | 42 | $13,860 | $7,207 | 52.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 173 | 275 | $20,625 | $6,419 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 88 | $9,328 | $4,969 | 53.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $11,858 | $4,390 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 31 | $7,130 | $3,872 | 54.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 34 | 34 | $13,600 | $3,684 | 27.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $7,260 | $2,880 | 39.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 45 | $4,500 | $2,741 | 60.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $2,210 | $1,203 | 54.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 83 | 83 | $39,010 | $15,450 | 39.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 47 | $10,810 | $7,238 | 67.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $17,940 | $6,905 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 79 | $12,324 | $6,609 | 53.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 149 | 262 | $19,650 | $5,966 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $13,310 | $5,621 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 89 | $9,434 | $5,332 | 56.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 28 | 28 | $9,240 | $5,047 | 54.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 62 | $6,200 | $3,431 | 55.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $10,800 | $2,969 | 27.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $5,610 | $2,298 | 41.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $2,890 | $1,678 | 58.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,400 | $992.93 | 41.4% |
About Dr. Jonathan Congeni, MD
Dr. Jonathan Congeni, MD is a Gastroenterology healthcare provider based in Canton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1558523563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Congeni, MD has received a total of $3,510 in payments from pharmaceutical and medical device companies, with $1,134 received in 2024. These payments were reported across 185 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,422).
As a Medicare-enrolled provider, Congeni has provided services to 2,763 Medicare beneficiaries, totaling 3,379 services with total Medicare billing of $267,368. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Canton, OH
- Active Since 06/30/2008
- Last Updated 05/12/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558523563
Products in Payments
- STELARA (Biological) $432.42
- SKYRIZI (Biological) $282.86
- RINVOQ (Biological) $246.00
- XIFAXAN (Drug) $231.82
- ENTYVIO (Biological) $227.74
- LINZESS (Drug) $134.88
- DUPIXENT (Biological) $100.43
- GIMOTI (Drug) $89.63
- Cimzia (Drug) $81.86
- CREON (Drug) $76.82
- XIFAXANIBSD (Drug) $74.76
- Humira (Biological) $72.76
- OMVOH (Drug) $66.52
- OCALIVA (Drug) $65.37
- XELJANZ (Drug) $65.13
- VIBERZI (Drug) $64.22
- EOHILIA (Drug) $57.83
- ZEPOSIA (Drug) $54.78
- VOWST (Biological) $52.93
- ZENPEP (Drug) $47.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Canton
Sanjiv Khetarpal, Md, MD
Gastroenterology — Payments: $18,059
Dr. Bruce Kalmin, Md, MD
Gastroenterology — Payments: $11,994
Dr. Michael Gurney, M.d, M.D
Gastroenterology — Payments: $11,079
Dr. Sanjiv Khullar, M.d, M.D
Gastroenterology — Payments: $5,658
Neal Patel, M.d, M.D
Gastroenterology — Payments: $4,420
Ellen Lintner, Pa-C, PA-C
Gastroenterology — Payments: $4,407